Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Why the study?
Does empagliflozin reduce blood pressure and improve markers of arterial stiffness and vascular resistance in patients with type 2 diabetes?
Population
Patients with type 2 diabetes
Authors
Discussion
Loading...
Member takes
Implication
Supports potential BP and vascular benefits in T2D; hypothesis-generating and requires RCT confirmation before practice change.
Structured PICO
Does empagliflozin reduce blood pressure and improve markers of arterial stiffness and vascular resistance in patients with type 2 diabetes?
P
Population
Patients with type 2 diabetes
I
Intervention
Empagliflozin
O
Outcome
Blood pressure, markers of arterial stiffness, and vascular resistancesurrogate
Empagliflozin improves blood pressure and markers of vascular health in patients with type 2 diabetes.
Cite This Study
Ćhilton et al. (2015) studied this question.